Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I know right, stocks go down and up daily. Inexperience to point out a down day when CANB has been going up almost daily, lol.
:
Watch the recovery Friday. Funny watching the critics jump all over a desperate seller. LMAO! Quite amusing
NASDAQ
CANB
Yep, agree Smart Money Continues to Accumulate Daily EOD.
Nasdaq Cometh.
Good to see Smart Investors don’t listen to years old negative opinions.
Next stop 6 month high, then yearly high.
First Quarter Revenue Growth-of 606% speaks volumes.
No denying it, Daily Accumulation Continues.
Misleading IMO, that has been said years ago. Yet CANB Continues to Grow and Expand it’s Growing Business Successfully.
Nothing better then Facts to prove CANB’s Continued Success in the industry.
Accumulation Continues Daily:
Best to Provide Facts on CANB Continued Growth and Expansion.....Just can't Trick Smart Money From Continued Accumulation Daily. Next Stop 6 Month High on the Chart.
Looks like EOD Accumulation Continued All week again. Goes to show CANB Fun to watch 2022...And Beyond. Smart Money knows CANB is making all the right moves, This is a big part why:
THE HIGHEST QUARTERLY REVENUE IN COMPANY HISTORY, Very Impressive Indeed:
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
May 18 2022 - 07:26AM
InvestorsHub NewsWire
Alert
Print
Share On Facebook
Strengthened Balance Sheet with Increases to $17.0 Million in Total Assets and $6.2 Million in Stockholders Equity
Spot On BG, boy I would hate to be one of the few on the sidelines now. CANB continues to make all the right moves. Facts are pretty solid:
:
Lol! Debt to build a massive seed to sale hemp-CBD company coupled with historic year after year revenue gains is a good thing. You have to expand to make the revenues increase and CANB is doing a fantastic job expanding and generating revenue. TSL* has a mind boggling 42 billion dollar "debt" but the company is growing massively.
There's good debt: expanding the company and making huge revenue. CANB example:
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Best to Provide Facts on CANB Continued Growth and Expansion.....Just can't Trick Smart Money From Continued Accumulation Daily. Next Stop 6 Month High on the Chart.
Looks like EOD Accumulation Continued All week again. Goes to show CANB Fun to watch 2022...And Beyond. Smart Money knows CANB is making all the right moves, This is a big part why:
THE HIGHEST QUARTERLY REVENUE IN COMPANY HISTORY, Very Impressive Indeed:
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
May 18 2022 - 07:26AM
InvestorsHub NewsWire
Alert
Print
Share On Facebook
Strengthened Balance Sheet with Increases to $17.0 Million in Total Assets and $6.2 Million in Stockholders Equity
HICKSVILLE, NY -- May 18, 2022 -- InvestorsHub NewsWire -- Can B Corp. (OTCQB: CANB) (“Can B'' or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, today announced the Company's financial results for the first quarter ended March 31, 2022.
Key Financial Highlights for Q1 2022
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
Solidified and integrated vertical processing capabilities from recent acquisitions
Advanced build-out of first CBD lounge in Miami, Florida
Continuing path for potential NASDAQ up-listing
Management Commentary
Marco Alfonsi, Can B’s Chief Executive Officer, stated, “We are extremely pleased with our tremendous quarterly results, having achieved the highest quarterly revenue in our company history. We generated the $1.9 million in quarterly revenue while reducing our cash burn as demonstrated by the decrease in adjusted EBITDA to $0.9 million. The strategic moves we have made over the past several months have completed our vertical processing capabilities and put us in great position to accelerate our revenue growth and strengthen our balance sheet. This quarter’s results prove our plans are working as our team continues its hard at work integrating and ramping up the various operations to continue this momentum into the future.”
Alfonsi concluded, “Can B is now a full-service hemp-derived cannabinoid company that can facilitate servicing the large box types as well as the boutique vape and smoke store. Our dramatic revenue improvements, coupled with our acquisitions and asset base increases, position us solidly to continue our application process for a NASDA up listing.”
Vertical Processing Capabilities
Secured hemp biomass and winterized crude to create over 13,000 Liters (1 Liter = 1.05 Quarts) of isomers, including Delta-8, with a potential wholesale value exceeding $10 million at today's market price. Can B's late 2021 acquired facilities in Colorado will receive harvested hemp biomass and convert it to winterized crude. These same facilities will then process it to distillate, then to isolate which will be shipped to Company-owned facilities in Florida and Tennessee to produce Delta-8 or other isomers, or to its manufacturing facility in Lacey, Washington for its line of CBD tinctures, salves, gels, and drops. This processing is expected to take 5-6 months to produce 13,000 liters of Delta-8 and other isomers with potential revenue of $10 million.
300,000 Square Foot Facility in McMinnville, Tennessee
Acquisition of Assets from TWS Pharma included leases on a total of 15,000 square foot of facilities located in Mead and Ft. Morgan Colorado.
Acquisition of Assets from Music City Botanicals added additional volume in extraction, isomer lab production, and R&D into the evolving isomer market with such products as Delta-10, CBG, CBN, and CBDA.
Financial Results for the Three Months Ended March 31, 2022:
Revenue: For the three months ended March 31, 2022, revenue was $1.9 million, an increase of $1.6 million, or 606%, compared with $0.3 million for the same period last year. The increase is due to the wind-down of restrictions related to the Covid-19 Pandemic surrounding elective surgeries, enabling an increase in the usage of the Company’s Duramed product lines and ultrasound device associated with patient recovery. Additionally, due to asset acquisitions in 2021, the Company’s Music City Botanical and Botanical Biotech brands related to an increase in sales compared to 2021 of $0.6 million.
Gross Profit: For the three months ended March 31, 2022, gross profit was $0.7 million, an increase of $0.4 million, or 291%, compared with $0.2 million for the same period last year. The resulting gross margin was 36.0%, compared with 75.0% for the same period last year.
Total Operating Expenses: For the three months ended March 31, 2022, total operating expenses were $3.9 million, an increase of $1.8 million, or 91%, compared with $2.0 million for the same period last year, as a direct result of professional fees and other accounting and legal fees related to the Company’s registration statement S-1 filing efforts.
Of note, $2.3 million of the Company's operating expenses for the three months ended March 31, 2022, were non-cash expenses, including depreciation, amortization, and stock-based compensation, compared to $0.5 million for the same period last year.
Operating Loss: For the three months ended March 31, 2022, operating loss was $3.2 million, an increase of $1.4 million, compared with an operating loss of $1.8 million for the same period last year.
Adjusted EBITDA Loss: For the three months ended March 31, 2022, Adjusted EBITDA loss was $0.9 million, a decrease of $0.4 million, or 30%, compared with an Adjusted EBITDA loss of $1.3 million for the same period last year, after deducting non-cash and one-time expenses.
Net Loss: For the three months ended March 31, 2022, net loss was $3.5 million, an increase of $1.3 million, or 60%, compared with $2.2 million for the same period last year. The EPS loss per share for the three months ended March 31, 2022, was ($1.10), compared to ($3.58) for the same period last year.
About Can B Corp.
Can B Corp. (OTCQB: CANB) is a health & wellness company providing the highest quality hemp-derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. operates R&D and production facilities in Lacey, WA, and Florida. To learn more about Can B Corp. and our comprehensive line of high-quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
For more information about Can B Corp., please visit: CanBCorp.com
Twitter @CanBCorp
Instagram @canbcorp
Facebook @ Can B Corp
YouTube
Exactly, CANB keeps making all the right moves, this Quarter alone was Spectacular. Of course there will always be a few rotten apples that will disagree no matter what Positive News is released. Constitutes for pure comical opinions.
Nasdaq Comith.
:
What? How ridiculous, but I'm not surprised one bit. I digress. Anyhow, CANB sells fantastic Hemp-CBD products online to every State in the union. Shm
A little DD goes s long way , folks
NASDAQ
CANB
Well said, lol.
CANB…Nasdaq Bound.
Definitely Nasdaq Bound, bring on the forward splits.
Next stop the 6 month high and so on.
Accumulation Continues by Smart Money with Vision.
Crossed the $6 mark today. Next step the 6 month high on the chart.
Nasdaq Bound…Period
SPot On, CANB makes another excellent move. Only a Fool would argue this.
FANTASTIC CANB NEWS:
https://www.globenewswire.com/news-release/2022/07/26/2485650/0/en/Can-B-Corp-Inks-Manufacturing-Distribution-Agreement-for-Superfood-Products-with-Forever-Brands-and-Brooke-Burke-via-BB-Body-Inc.html
Initial 3-Year Worldwide Agreement
HICKSVILLE, NY, July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products and other wellness products and programs, is pleased to announce the signing of a Manufacturing and Distribution Agreement with Forever Brands to produce a line of nutritional Superfoods drink mix for Brooke Burke and her company, BB Body, Inc.
The initial 3-year worldwide agreement covers the sale, manufacturing and distribution of the Superfood and related nutritional products. Can B subsidiaries Imbibe Wellness Solutions is the exclusive direct to consumer seller of the products and Pure Health Products is a manufacturer and distributor of the products. The products will be marketed under the Longevity by Brooke Burke trademarks and brand. The partnership includes a powdered drink superfood mix, all-natural metabolic energy drink and other products that may be mutually agreed from time to time.
Brooke Burke, an American television personality, fitness personality, author, actress and businessperson, will market, endorse, and promote the products as a monthly online subscription model under her company BB Body, Inc..
The anticipated launch date is late third quarter 2022.
NASDAQ!!!!!!!!!!
CANB
Excellent, another Sweet deal for CANB, add to that the Spectacular Quarter they just had.
:
CANB Can B Corp. Inks Manufacturing & Distribution Agreement for Superfood Products with Forever Brands and Brooke Burke via BB Body, Inc.
https://www.globenewswire.com/news-release/2022/07/26/2485650/0/en/Can-B-Corp-Inks-Manufacturing-Distribution-Agreement-for-Superfood-Products-with-Forever-Brands-and-Brooke-Burke-via-BB-Body-Inc.html
Initial 3-Year Worldwide Agreement
HICKSVILLE, NY, July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products and other wellness products and programs, is pleased to announce the signing of a Manufacturing and Distribution Agreement with Forever Brands to produce a line of nutritional Superfoods drink mix for Brooke Burke and her company, BB Body, Inc.
The initial 3-year worldwide agreement covers the sale, manufacturing and distribution of the Superfood and related nutritional products. Can B subsidiaries Imbibe Wellness Solutions is the exclusive direct to consumer seller of the products and Pure Health Products is a manufacturer and distributor of the products. The products will be marketed under the Longevity by Brooke Burke trademarks and brand. The partnership includes a powdered drink superfood mix, all-natural metabolic energy drink and other products that may be mutually agreed from time to time.
Brooke Burke, an American television personality, fitness personality, author, actress and businessperson, will market, endorse, and promote the products as a monthly online subscription model under her company BB Body, Inc..
The anticipated launch date is late third quarter 2022.
Correct, EOD Loading Continues Daily. Goes to show, just can’t trick Smart Money from not Buying at this discounted price.
Not to Mention the Outstanding Quarter!
:
CANB = Always heavily loaded end of day!
NASDAQ
CANB
Up almost 15% Today! No Wonder EOD Loading! Excellent Quarterly Facts are Impressive! Only a Total Fool would criticize at this point.
:
LMAO! Facts vs TOTRAL BULLSHIT
FACTS: Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
Spot On, With those Positive Facts, only a Total Fool would disagree, lol.
LMAO! Facts vs TOTRAL BULLSHIT
FACTS: Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
Correct, BG. CANB is making all the right moves. Even non followers can’t pull away any more.
Nasdaq Bound!
Yep, +8% today. Smart Money will not be left behind as we are about to break the 3 month high. Best high lights of the Quarter says it all:
:
Key Financial Highlights for Q1 2022
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
Solidified and integrated vertical processing capabilities from recent acquisitions
Advanced build-out of first CBD lounge in Miami, Florida
Continuing path for potential NASDAQ up-listin
Spot On, CANB is Expanding and Growing Rapidly.
Here it is again for the individual who is in denial.
:
Key Financial Highlights for Q1 2022
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
Solidified and integrated vertical processing capabilities from recent acquisitions
Advanced build-out of first CBD lounge in Miami, Florida
Continuing path for potential NASDAQ up-listing
No Wonder All The Continued Accumulation. CANB Just Making All the right Future Moves.
:
Key Financial Highlights for Q1 2022
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
Solidified and integrated vertical processing capabilities from recent acquisitions
Advanced build-out of first CBD lounge in Miami, Florida
Continuing path for potential NASDAQ up-listing
Management Commentary
Correct, Upward Trajectory Continues. CANB closing in on its 3 month high as Accumulation Continues.
Correct Nasdaq Coming, no wonder Investors continue to Load and Hold these golden shares.
CANB Continues to make All the Right Moves, AND…add to the list Record Quarterly Earnings, Impressive.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Spot On, CANB Accumulation Continues. Easy to see why, Smart Investors know Nasdaq is coming.
CANB Continues to make All the Right Moves, AND…add to the list Record Quarterly Earnings, Impressive.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Correct, it’s only a matter of time before CANB goes to the Nasdaq. Nice almost 14% Gain today :)
CANB Continues to make All the Right Moves, AND…add to the list Record Quarterly Earnings, Impressive.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Spot On, it’s only a matter of time before CANB goes to the Nasdaq.
CANB Continues to make All the Right Moves, AND…add to the list Record Quarterly Earnings, Impressive.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Misleading.. Again. CANB Continues to make All the Right Moves, add to the list Record Quarterly Earnings, Impressive.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
THE HIGHEST QUARTERLY REVENUE IN COMPANY HISTORY, Very Impressive Indeed:
Can B Corp. Reports First Quarter Revenue Growth of 606% to $1.9 Million, the Highest Quarterly Revenue in Company History
May 18 2022 - 07:26AM
InvestorsHub NewsWire
Alert
Print
Share On Facebook
Strengthened Balance Sheet with Increases to $17.0 Million in Total Assets and $6.2 Million in Stockholders Equity
HICKSVILLE, NY -- May 18, 2022 -- InvestorsHub NewsWire -- Can B Corp. (OTCQB: CANB) (“Can B'' or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, today announced the Company's financial results for the first quarter ended March 31, 2022.
Key Financial Highlights for Q1 2022
Revenue increased 606% to $1.9 million
Gross profit increased 291% to $0.7 million
Adjusted EBITDA loss decreased 30% to $0.9 million
Total assets increased to $17.0 million
Total stockholders’ equity increased to $6.2 million
Key Business Highlights for Q1 2022
Solidified and integrated vertical processing capabilities from recent acquisitions
Advanced build-out of first CBD lounge in Miami, Florida
Continuing path for potential NASDAQ up-listing
Management Commentary
Marco Alfonsi, Can B’s Chief Executive Officer, stated, “We are extremely pleased with our tremendous quarterly results, having achieved the highest quarterly revenue in our company history. We generated the $1.9 million in quarterly revenue while reducing our cash burn as demonstrated by the decrease in adjusted EBITDA to $0.9 million. The strategic moves we have made over the past several months have completed our vertical processing capabilities and put us in great position to accelerate our revenue growth and strengthen our balance sheet. This quarter’s results prove our plans are working as our team continues its hard at work integrating and ramping up the various operations to continue this momentum into the future.”
Alfonsi concluded, “Can B is now a full-service hemp-derived cannabinoid company that can facilitate servicing the large box types as well as the boutique vape and smoke store. Our dramatic revenue improvements, coupled with our acquisitions and asset base increases, position us solidly to continue our application process for a NASDA up listing.”
Vertical Processing Capabilities
Secured hemp biomass and winterized crude to create over 13,000 Liters (1 Liter = 1.05 Quarts) of isomers, including Delta-8, with a potential wholesale value exceeding $10 million at today's market price. Can B's late 2021 acquired facilities in Colorado will receive harvested hemp biomass and convert it to winterized crude. These same facilities will then process it to distillate, then to isolate which will be shipped to Company-owned facilities in Florida and Tennessee to produce Delta-8 or other isomers, or to its manufacturing facility in Lacey, Washington for its line of CBD tinctures, salves, gels, and drops. This processing is expected to take 5-6 months to produce 13,000 liters of Delta-8 and other isomers with potential revenue of $10 million.
300,000 Square Foot Facility in McMinnville, Tennessee
Acquisition of Assets from TWS Pharma included leases on a total of 15,000 square foot of facilities located in Mead and Ft. Morgan Colorado.
Acquisition of Assets from Music City Botanicals added additional volume in extraction, isomer lab production, and R&D into the evolving isomer market with such products as Delta-10, CBG, CBN, and CBDA.
Financial Results for the Three Months Ended March 31, 2022:
Revenue: For the three months ended March 31, 2022, revenue was $1.9 million, an increase of $1.6 million, or 606%, compared with $0.3 million for the same period last year. The increase is due to the wind-down of restrictions related to the Covid-19 Pandemic surrounding elective surgeries, enabling an increase in the usage of the Company’s Duramed product lines and ultrasound device associated with patient recovery. Additionally, due to asset acquisitions in 2021, the Company’s Music City Botanical and Botanical Biotech brands related to an increase in sales compared to 2021 of $0.6 million.
Gross Profit: For the three months ended March 31, 2022, gross profit was $0.7 million, an increase of $0.4 million, or 291%, compared with $0.2 million for the same period last year. The resulting gross margin was 36.0%, compared with 75.0% for the same period last year.
Total Operating Expenses: For the three months ended March 31, 2022, total operating expenses were $3.9 million, an increase of $1.8 million, or 91%, compared with $2.0 million for the same period last year, as a direct result of professional fees and other accounting and legal fees related to the Company’s registration statement S-1 filing efforts.
Of note, $2.3 million of the Company's operating expenses for the three months ended March 31, 2022, were non-cash expenses, including depreciation, amortization, and stock-based compensation, compared to $0.5 million for the same period last year.
Operating Loss: For the three months ended March 31, 2022, operating loss was $3.2 million, an increase of $1.4 million, compared with an operating loss of $1.8 million for the same period last year.
Adjusted EBITDA Loss: For the three months ended March 31, 2022, Adjusted EBITDA loss was $0.9 million, a decrease of $0.4 million, or 30%, compared with an Adjusted EBITDA loss of $1.3 million for the same period last year, after deducting non-cash and one-time expenses.
Net Loss: For the three months ended March 31, 2022, net loss was $3.5 million, an increase of $1.3 million, or 60%, compared with $2.2 million for the same period last year. The EPS loss per share for the three months ended March 31, 2022, was ($1.10), compared to ($3.58) for the same period last year.
About Can B Corp.
Can B Corp. (OTCQB: CANB) is a health & wellness company providing the highest quality hemp-derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. operates R&D and production facilities in Lacey, WA, and Florida. To learn more about Can B Corp. and our comprehensive line of high-quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
For more information about Can B Corp., please visit: CanBCorp.com
Twitter @CanBCorp
Instagram @canbcorp
Facebook @ Can B Corp
YouTube
Misleading…Again. CANB hitting a high of $5.50 today. Clearly, Accumulation and Holding Continues by Smart Money.
:
Huge Future for CANB.
No wonder All Eyes are focused on CANB 24/7.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Misleading…Again. Accumulation and Holding Continues by Smart Money.
:
Huge Future for CANB.
No wonder All Eyes are focused on CANB 24/7.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Great Interview! CANB continues to make All the right moves 2022- And Beyond!
Loved this part;
Our second operating division is the hemp division," continued Alfonsi. "For Q3 we made some major acquisitions," he shared. "We increased our balance sheet assets to over $16 million as of 12-31-2021," said Alfonsi. "We're able to be vertically integrated from biomass and hemp crude thru to isolate, and a full line of retain CBD products and various isomers."
"With our Miami operation, we have modeled a consumption lounge adjacent to our lab production operations and hope to open similar operations in select cities ove the next several months. "Once opened in locations where State and Federal laws allow, you'll be able to purchase CBD, Delta-8, or Delta-10 products, and still have the ability to enjoy them in a lounge, which in the evening will turn into a nightclub with live entertainment," he shared, adding that "the lounge will also serve infused beverages and have that CBD Experience being located adjacent to an actual production lab".
"Our third operating division is Duramed, which is our medical device company," said Alfonsi, before elaborating on the Company's wearable technology. "We are now in Michigan, where we have doubled our business," he shared, adding that the Company is also doing business in New York.
Jolly then commented on the Company's recently announced partnerships with PrimeX and American Development Partners. "In March, we signed the Brazilian Joint Venture with PrimeX," said Alfonsi, adding that CBD was not legal in Brazil until recently. "We have final products that are ready to be shipped to Brazil, and hopefully local physicians will be writing scripts on behalf of our products for their patients."
"With American Development Partners, it is a new concept for us," continued Alfonsi. "We were able to secure the American Development Partners to create and raise up to $200 million to build as many as 50 consumption lounges that are available to be assigned to our labs."
"What kind of new isomers are scheduled to be released within the next few months?" asked Jolly. "Right now we are able to do Delta-8," explained Alfonsi. "CBD is still a very low price, but once you convert that isolate into an isomer the price jumps," he explained, before elaborating on the different isomers. "We've been able to increase our revenues and margins for the simple reason that we are able to create these isomers."
To close the interview, Alfonsi elaborated on the Company's significant growth, and encouraged listeners and shareholders to keep up-to-date on their current plans and projects.
To hear Marco Alfonsi's entire interview, follow the link to the podcast here: https://audioboom.com/posts/8069795-can-b-corp-discusses-2022-growth-opportunities-and-new-partnerships-on-the-stock-day-podcast.
Wow! That’s Massive Revenue Increase Indeed!
CANB Continues to Impress $$$$$
Nasdaq Bound
:
Revenues increased $2,894,160 from $1,709,669 in 2020 to $4,603,829 in 2021."
Misleading, CANB continues to make all the right moves. So much for the going out of business fiasco by end of year.
Smart Money will Patiently Hold and Continue to Accumulate.
Huge Future for CANB.
No wonder All Eyes are focused on CANB 24/7.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Spot On, Huge Future for CANB.
No wonder All Eyes are focused on CANB 24/7.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
No worries, the dedicated Patience will pay off greatly. love this part of the PR.
Marco Alfonsi, Can B's Chief Executive Officer, stated, "We are very excited for this expansion opportunity, with our first location expected to open in the tourist popular Wynwood section of Miami, Florida in April. Our CBD Lounges will encompass food, drink, and entertainment and highlight our health and wellness CBD products. With ADP, we have a well-recognized and experienced partner sharing our vision to build out our CBD Lounges. We have a plan to roll out a number of locations over the next few years and believe it will be a large contributor of revenue to our company without dilution to our shareholders."
Correct, Smart Money will patiently buy and wait, CANB making all the right moves.
Accumulation and Holding Continues by Smart Money.
:
Huge Future for CANB.
No wonder All Eyes are focused on CANB 24/7.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Yep, Great News Continues for CANB Indeed. No wonder Loading and Holding Continues.
Can B Corp. Executes Joint Venture with PrimeX Making its CBD Products Available in Brazil
Thu, March 3, 2022, 6:00 AM
In this article:
CANBD
+13.73%
Enabling Access to the 4th Largest Pharmaceutical Market in the World and its 210 Million Consumers
HICKSVILLE, NY / ACCESSWIRE / March 3, 2022 / Can B Corp. (OTCQB:CANBD) ("Can B'' or the "Company"), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, is pleased to announce its formation of a joint venture with PrimeX, a marketing, sales, and distribution company, for its CBD products in Brazil.
PrimeX has a contract with Biocase Brasil to produce CBD products for the Brazilian market.
Biocase is a company focused on: local distribution, an intensive education program for doctors (MDs), production of oils, capsules, and creams through local facilities, and the development of a biotech laboratory for cannabis testing and extraction.
Biocase Brasil has a strong network of doctors in Brazil and provides education, research, products development, and tests for the Brazilian market. Brazil relies on medical clinical trials to test CBD products for new categories, such as beauty, veterinary use, and food, before regulation permits the distribution to pharmacies and online sales. BiocaseBrasil patients' also have access to prescriptions and Anvisa licenses!
PrimeX services 120,000 retailers in Brazil, which includes markets, pharmacies, and bodegas, a country that recently approved the sale of CBD products in pharmacies. The joint venture will utilize PrimeX's existing distribution relationships in Brazil.
The largest country in South America, Brazil is the fourth biggest pharmaceutical market in the world. The Brazilian National Health System is one of the largest public health systems in the world. In 2019, Brazil had 114,352 community pharmacies (76.8% privately owned), which represent the first point of access to healthcare in Brazil due to their wide distribution.
Medical cannabis and CBD are expected to surge in Brazil with the passage of new legislation, with estimates that the sector could reach $4.7 billion in sales in the next three years. Up until recently, CBD in Brazil was permitted only for medical use with authorization from the National Sanitary Surveillance Agency. Regulations are in place for medical cannabis and hemp opening up a market of 210 million consumers.
There are only a few companies in Brazil - CBD Vida being one- selling CBD-based pharmaceuticals through prescription and medical reports, Only a handful of importers have established distribution in Brazil, including GW Pharmaceuticals, Biocase Brazil, which sells its Sativex CBD-based medicine in pharmacies, and Biocase sells Allandiol Full and Broad.
Mario Lacourt, PrimeX's Chief Executive Officer, stated, "We are very excited to roll out Can B's CBD products in Brazil. After careful consideration, Biocase Brasil chose Can B for its high standards of manufacturing and processing and quality products. The CBD category in Brazil is ever-expanding to new categories and we are very well-positioned to distribute Can B's products to the majority of pharmacies, markets, and bodegas in Brazil."
Marco Alfonsi, Can B's Chief Executive Officer, stated, "This is a significant expansion milestone for our company as Brazil is the fourth biggest pharmaceutical market in the world and we now have access to this huge market via PrimeX. The CBD opportunity in Brazil is emerging with recently passed legislation that is opening up the market to its 210 million people. We look forward to working closely with PrimeX and utilizing its existing relationships with pharmacies in Brazil."
About PrimeX
PrimeX distributes and markets hemp, CBD, D8 smokable, and consumable products in the USA and internationally. PrimeX works with clients to fulfill all their hemp-derived products globally by partnering with companies alike (for example, Dicina 120,000+ points of sale). With access to raw material, pre-roll smokes rolled at 1600/minute to pharmaceutical grade products, PrimeX works to provide top-shelf consumer access.
For additional information, please visit:
https://sateevajoints.com
https://www.biocasebrasil.com
About Can B Corp.
Can B Corp. (OTCQB:CANB) is a health & wellness company providing the highest quality hemp-derived cannabinoid products, including under its own brands of Canbiola, Seven Chakras, NuWellness, Pure Leaf Oil, and Duramed. Can B utilizes multi-channel distribution to reach consumers, including medical facilities, doctor offices, retailers, online and direct. Can B Corp. operates R&D and production facilities in Lacey, WA, and Florida. To learn more about Can B Corp. and our comprehensive line of high-quality products, please visit: Canbiola.com and www.CanBCorp.com, follow Can B Corp on Instagram and Facebook, or visit one of the 1,000+ retail outlets that carry Can B Corp. products.
For more information about Can B Corp., please visit: CanBCorp.com
Twitter @CanBCorp
Instagram @canbcorp
Facebook @ Can B Corp
YouTube
Forward-Looking Statements
Forward-looking statements and risks and uncertainties discussed in this release contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape, or manner of our future financial condition or stock price. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of the latest information, future events, or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
Investors and Media:
IR@canbiola.com
(917) 658-7878
Accumulation and Holding Continues by Smart Money.
:
Huge Future for CANB.
No wonder All Eyes are focused on CANB 24/7.
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Right, lol. CANB going to continue it trajectory North in the weeks and months ahead. As All Eyes follow....we shall see it happen,
Wow, More eyes Focused on CANB Now,
Easy to see why:
*Debt Elimination Continues
*Expansion Continues
*New Products
*New Partners
*Continued Growth
*Nasdaq Coming
Buying more as well. $20 easily in the coming weeks and months.
Nasdaq Bound
Yep, Loading and Holding.